EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry

Basit Öğe Kaydı
dc.contributor.authorGümüş, M.
dc.contributor.authorOzkan, M.
dc.contributor.authorYilmaz, U.
dc.contributor.authorTekin, S. B.
dc.contributor.authorDemir, C.
dc.contributor.authorErdogan, A.
dc.contributor.authorDane, F.
dc.date.accessioned2025-05-10T19:27:50Z
dc.date.issued2017
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstract[No abstract available]
dc.identifier.endpageS2142
dc.identifier.issn1556-0864
dc.identifier.issn1556-1380
dc.identifier.issue11
dc.identifier.scopusqualityQ1
dc.identifier.startpageS2142
dc.identifier.urihttps://hdl.handle.net/20.500.14730/7074
dc.identifier.volume12
dc.identifier.wosWOS:000463860801715
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of Thoracic Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250302
dc.subjectnon-small cell lung cancer
dc.subjectErlotinib
dc.subjectEGFR mutation
dc.titleEGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu